Following on from a successful Superbugs USA summit, SMi Group presents the 19th annual Superbugs & Superdrugs European conference which returns to Central London on 20th and 21st March 2017.
London’s flagship show in the global Superbugs portfolio of events has been expanding horizons on the growing threat of anti-microbial resistance (AMR) and infectious disease for almost two decades. It will once again provide a focal point for its growing “superbugs” community comprising of scientific leaders, funding bodies and drug discovery specialists, to network, exchange novel solutions and consolidate current strategies.
The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered by a panel of speakers who will hone in on key issues such as industry funding opportunities, the use of animal models in drug research and antimicrobial peptides.
Highlights will include a special regulatory spotlight on antibacterial drug development presented by Sumathi Nambiar, Director of the FDA Division of Anti-Infective Products.
FEATURED SPEAKERS INCLUDE:
WHATS ON THE AGENDA FOR 2017?
See the full program here
Send this to friend